Home › Funds › Hikari Tsushin, Inc. › ABT

Hikari Tsushin, Inc. position in ABT

ABBOTT LABORATORIES · Health Care

Hikari Tsushin, Inc. reported holding 30,604 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 0.20% of its reported portfolio and ranking #33 among its reported holdings. Hikari Tsushin, Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)30.60K sh
Reported value held$3.02M
Portfolio Weight0.20%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hikari Tsushin, Inc.'s ABT position evolved

Hikari Tsushin, Inc. first disclosed a stake in ABT in Q3 2023 at 32,870 shares (US$3.2M). The position peaked in Q2 2025 at 32,870 shares, worth US$4.5M. Across 13 filings, Hikari Tsushin, Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 30,604 shares valued at US$3.0M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.87K $3.18M New
Q4 2023 32.87K $3.62M Hold
Q1 2024 32.87K $3.74M Hold
Q2 2024 32.87K $3.42M Hold
Q3 2024 32.87K $3.75M Hold
Q4 2024 32.87K $3.72M Hold
Q1 2025 32.87K $4.36M Hold
Q2 2025 32.87K $4.47M Hold
Q3 2025 32.87K $4.40M Hold
Q4 2025 32.87K $4.12M Hold
Q1 2026 32.87K $3.37M Hold
Q2 2026 30.60K $2.78M Reduce
Q3 2026 30.60K $3.02M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Hikari Tsushin, Inc. held ABT?

Hikari Tsushin, Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hikari Tsushin, Inc.'s current position in ABT?

As of Q3 2026, Hikari Tsushin, Inc. holds 30.60K shares of ABT (ABBOTT LABORATORIES), valued at $3.02M, representing 0.20% of its reported portfolio and ranking #33.

Has Hikari Tsushin, Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Hikari Tsushin, Inc. held unchanged its position in ABT. The position peaked in Q2 2025 at 32.87K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.